All compounds
SARMs and receptor modulatorsClinical-stage compound

LGD-4033 / Ligandrol

An investigational selective androgen receptor modulator with limited human trial data and no authorised consumer indication.

Reference reviewed 5 September 2026 · No dosing or protocol information
01

What the name refers to

An investigational selective androgen receptor modulator with limited human trial data and no authorised consumer indication.

02

Evidence and regulatory context

Human clinical research exists, but this entry is not a broadly authorised consumer medicine. Trial results apply to the studied formulation, population and endpoints—not automatically to products sold online.

03

Reading product records

Research-market surveys have repeatedly found label mismatches in this category. A record should therefore keep the claimed molecule, measured identity and measured amount separate, and should never treat the word “SARM” as evidence of approval or safety.

04

Primary research links

Use current regulator and study records rather than treating a catalogue description as medical evidence.